Search
for
Sort by
Research 121–150 of 1000+
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Repurposing of approved cardiovascular drugs
- TGFβ and cancer metastasis: an inflammation link
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
- S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma
- Oncogenic senescence: a multi-functional perspective
- Responsive Microneedles as a New Platform for Precision Immunotherapy
- Hirsutism
- Skin Diseases in Horses
- Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models
- The exploration of mitochondrial‐related features helps to reveal the prognosis and immunotherapy methods of colorectal cancer
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Case Report: Pulsed electric field treatment of metastatic liver disease demonstrating a possible abscopal response
- Novel Insights into TSC22D Family Genes in Metabolic Diseases and Cancer
- Multi-omics analysis unveils the role of cancer-associated fibroblasts in cutaneous squamous cell carcinoma
- What is your diagnosis? Fine‐needle aspirate from a subcutaneous preputial mass in a ferret
- The PDGF/PDGFR pathway as a drug target
- Transforming growth factor-β in stem cells and tissue homeostasis
- Biomedical Applications of Layer‐by‐Layer Self‐Assembly for Cell Encapsulation: Current Status and Future Perspectives
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for <i>In Vivo</i> CRISPR/Cas-Based Genome Editing
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Roles of Wnt7a in embryo development, tissue homeostasis, and human diseases
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Clinical Development of Topoisomerase-Interactive Drugs
- Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
- Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies
- The pioneer factor SOX9 competes for epigenetic factors to switch stem cell fates
- Melatonin Receptors and Their Role in Human Diseases